The maker of a discontinued heartburn medication has settled thousands of lawsuits that claim the pills cause . New Jersey-based manufacturer Sanofi has reached an agreement to settle 4,000 lawsuits linking the active ingredient in Zantac - rantidine - to cancers.Zantac, an over-the-counter pill for heartburn and indigestion, was pulled from shelves in 2020 after animal studies found that rantidine released 'probable human carcinogens' linked to .
Load More
Load More